Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Henry

Showing results (91-100 of 139) with videos related to

Pageof 14
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|July 23, 2008
Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseasesJason V Baker, Grace Peng, Joshua Rapkin, et al.
AIDS (London, England)|May 21, 2005
Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposureJudith S Currier, Michelle A Kendall, Robert Zackin, et al.
Journal of Medicinal Chemistry|July 9, 2015
Novel Azido-Iodo Photoaffinity Ligands for the Human Serotonin Transporter Based on the Selective Serotonin Reuptake Inhibitor (S)-CitalopramVivek Kumar, Nageswari Yarravarapu, David J Lapinsky, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2011
High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral TherapyKristin E Mondy, John Gottdiener, E Turner Overton, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 19, 2013
A randomized, double-blind comparison of single-tablet regimen elvitegravir/cobicistat/emtricitabine/tenofovir DF vs ritonavir-boosted atazanavir plus emtricitabine/tenofovir DF for initial treatment of HIV-1 infection: analysis of week 144 resultsNathan Clumeck, Jean-Michel Molina, Keith Henry, et al.
American Journal of Epidemiology|December 17, 2008
The study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN Study)Claudia Vellozzi, John T Brooks, Timothy J Bush, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 6, 2006
A randomized crossover study to determine bioequivalence of generic and brand name nevirapine, zidovudine, and lamivudine in HIV-negative women in IndiaHeather E Vezina, Keith Henry, G D Ravindran, et al.
The Journal of Infectious Diseases|December 7, 2017
Prevalence, Incidence, and Clearance of Anal High-Risk Human Papillomavirus Infection Among HIV-Infected Men in the SUN StudyPragna Patel, Tim Bush, Erna Milunka Kojic, et al.
AIDS Care|February 5, 2011
Factors associated with non-adherence to antiretroviral therapy in the SUN studyMelanie Kyser, Kate Buchacz, Timothy J Bush, et al.
The Lancet. Infectious Diseases|June 9, 2014
Switching to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of non-nucleoside reverse transcriptase inhibitor with emtricitabine and tenofovir in virologically suppressed adults with HIV (STRATEGY-NNRTI): 48 week results of a randomised, open-label, phase 3b non-inferiority trialAnton Pozniak, Martin Markowitz, Anthony Mills, et al.
Pageof 14

Showing results (91-100 of 139) with videos related to

Sort By:
Pageof 14
Journal of Acquired Immune Deficiency Syndromes (1999)|July 23, 2008
Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseasesJason V Baker, Grace Peng, Joshua Rapkin, et al.
AIDS (London, England)|May 21, 2005
Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposureJudith S Currier, Michelle A Kendall, Robert Zackin, et al.
Journal of Medicinal Chemistry|July 9, 2015
Novel Azido-Iodo Photoaffinity Ligands for the Human Serotonin Transporter Based on the Selective Serotonin Reuptake Inhibitor (S)-CitalopramVivek Kumar, Nageswari Yarravarapu, David J Lapinsky, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2011
High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral TherapyKristin E Mondy, John Gottdiener, E Turner Overton, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 19, 2013
A randomized, double-blind comparison of single-tablet regimen elvitegravir/cobicistat/emtricitabine/tenofovir DF vs ritonavir-boosted atazanavir plus emtricitabine/tenofovir DF for initial treatment of HIV-1 infection: analysis of week 144 resultsNathan Clumeck, Jean-Michel Molina, Keith Henry, et al.
American Journal of Epidemiology|December 17, 2008
The study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN Study)Claudia Vellozzi, John T Brooks, Timothy J Bush, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 6, 2006
A randomized crossover study to determine bioequivalence of generic and brand name nevirapine, zidovudine, and lamivudine in HIV-negative women in IndiaHeather E Vezina, Keith Henry, G D Ravindran, et al.
The Journal of Infectious Diseases|December 7, 2017
Prevalence, Incidence, and Clearance of Anal High-Risk Human Papillomavirus Infection Among HIV-Infected Men in the SUN StudyPragna Patel, Tim Bush, Erna Milunka Kojic, et al.
AIDS Care|February 5, 2011
Factors associated with non-adherence to antiretroviral therapy in the SUN studyMelanie Kyser, Kate Buchacz, Timothy J Bush, et al.
The Lancet. Infectious Diseases|June 9, 2014
Switching to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of non-nucleoside reverse transcriptase inhibitor with emtricitabine and tenofovir in virologically suppressed adults with HIV (STRATEGY-NNRTI): 48 week results of a randomised, open-label, phase 3b non-inferiority trialAnton Pozniak, Martin Markowitz, Anthony Mills, et al.
Pageof 14